Accessibility Menu
 
Resverlogix logo

Resverlogix

(OTC) RVXCF

Current Price$0.08
Market Cap$24.86M
Since IPO (2012)-96%
5 Year-89%
1 Year+155%
1 Month+12%

Resverlogix Financials at a Glance

Market Cap

$24.86M

Revenue (TTM)

$0.00

Net Income (TTM)

$7.08M

EPS (TTM)

$-0.03

P/E Ratio

-3.15

Dividend

$0.00

Beta (Volatility)

0.55 (Low)

Price

$0.08

Volume

530

Open

$0.07

Previous Close

$0.08

Daily Range

$0.07 - $0.08

52-Week Range

$0.02 - $0.21

RVXCF News

No articles available.

RVXCF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Resverlogix

Industry

Biotechnology

Employees

18

CEO

Donald J. McCaffrey

Headquarters

Calgary, AB T3E 6L1, CA

RVXCF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

16%

Return on Assets

-68%

Earnings Yield

-31.75%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.86M

Shares Outstanding

315.92M

Volume

530

Short Interest

0.00%

Avg. Volume

12.03K

Financials (TTM)

Gross Profit

$331.29K

Operating Income

$4.65M

EBITDA

$4.25M

Operating Cash Flow

$3.89M

Capital Expenditure

$472.00K

Free Cash Flow

$4.36M

Cash & ST Invst.

$99.00K

Total Debt

$81.97M

Resverlogix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$105.81K

N/A

Gross Margin

0.00%

N/A

Market Cap

$24.86M

N/A

Market Cap/Employee

$1.31M

N/A

Employees

19

N/A

Net Income

$940.46K

+78.9%

EBITDA

$303.00K

+133.3%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$19.45M

-191.2%

Accounts Receivable

$766.00K

+410.7%

Inventory

$464.00K

-80.4%

Long Term Debt

$0.00

N/A

Short Term Debt

$19.51M

+188.1%

Return on Assets

-68.31%

N/A

Return on Invested Capital

16.10%

N/A

Free Cash Flow

$913.00K

-1701.8%

Operating Cash Flow

$818.00K

-554.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZHCLFZenith Capital Corp.
$0.13+18.18%
MEDIFMediPharm Labs Corp.
$0.05+0.20%
FNCHFinch Therapeutics Group, Inc.
$12.00-6.18%
CLYYFCelyad Oncology S.A.
$0.35+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.12-0.07%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About RVXCF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.